| Old Articles: <Older 1311-1320 Newer> |
 |
Pharmaceutical Executive January 1, 2006 Maggie Helmig |
Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors.  |
Pharmaceutical Executive January 1, 2006 Gene Guselli |
Marketing to Professionals: The Power of Positive Feedback Boost doctors' confidence in your brand by validating their prescription decisions.  |
Pharmaceutical Executive January 1, 2006 Peter Thompson |
Sales Management: The Wonders of Wireless Pharmaceutical reps can recover 30 minutes of downtime everyday with 24/7 connectivity to the Internet.  |
Pharmaceutical Executive January 1, 2006 Lou Morris |
Back Page: Nailing Down DTC Promotion Before the FDA and industry can find a solution to direct to consumer promotion, they need to nail down the problem.  |
Pharmaceutical Executive January 1, 2006 Cinquegrana & Lloyd |
Legal: Shifting Perspective on Off-Label Promotion A recent court case points to the government's shifting perspective on how it prosecutes companies for promoting off-label. Instead of criminal charges, hefty corporate integrity agreements might be in store.  |
Food Processing January 2006 Dave Fusaro |
Editor's Plate: Misplaced Blame and Ignorance The Institute of Medicine report on food advertising and childhood obesity is a serious indictment, but it is based on outdated research.  |
BusinessWeek January 16, 2006 David Kiley |
Television: Counting The Eyeballs In the TiVo Age, Madison Ave is turning to services that explain which ads work.  |
CRM January 1, 2006 David Myron |
Calling the Cops on Telemarketers This is an example of a simple market research campaign becoming a botched effort, resulting in a call to the police.  |
CRM January 1, 2006 Lior Arussy |
Is Your Product Really That Great? Loyalty programs won't work if a company's core product or service is perceived to have little or no value.  |
CRM January 1, 2006 Agarwal & Schumacher |
Put More Feet on the Street To extract more value from existing sales machinery, B2B companies must address fundamental sales productivity inhibitors, focusing first on process, policy, and guideline improvements.  |
| <Older 1311-1320 Newer> Return to current articles. |